Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
<p><strong>Objectives</strong></p><p>Treat to target recommendations for PsA state that the target of treatment should be remission or, at the very least, low disease activity. Different clinical indexes have been proposed to define these disease states including the mi...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Oxford University Press
2018
|